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Early migration of tibial components, which can be accurately 
measured with radiostereometric analysis (RSA), has been 
shown to predict future aseptic loosening (Ryd et al. 1995, 
Pijls et al. 2012b). Uncemented components typically display 
a biphasic migration pattern with high initial migration before 
stabilization (Pijls et al. 2012a, Wilson et al. 2012, Henricson 
and Nilsson 2016), while cemented components are initially 
more stable as the cement provides instant fi xation, yet contin-
uous bone resorption at the cement–bone interface may result 
in continuous migration (Nilsson et al. 2006, van Hamers-
veld et al. 2017). Given the importance of stabilization in the 
fi rst months after implantation, one method to improve bone 
ingrowth after uncemented total knee arthroplasty (TKA) is 
the application of osteoconductive hydroxyapatite (HA) coat-
ings (Nelissen et al. 1998, Carlsson et al. 2005).
Most HA coatings are plasma sprayed onto the porous 
beaded implant surface area. Plasma spraying is a “line of 
sight” technique and therefore only able to coat the substrate 
surface (Hansson et al. 2008). Contrarily, Peri-Apatite HA 
(PA) (Stryker, Mahwah, NJ, USA)is an alternative technique 
to deposit HA from an aqueous solution at room temperature, 
thereby increasing the coverage of HA onto the 3D beaded 
implant surface (Serekian 2004). However, without the effect 
of high temperatures up to 20,000 ºC associated with plasma 
spraying, the HA remains pure and 100% crystalline, while a 
lower crystallinity has been shown to improve the bioactiv-
ity and resorption profi le of HA (Overgaard et al. 1999, Ser-
ekian 2004). In addition, the adhesion of the relatively thin 
PA layer (of 20 µm compared with 50–75 µm for most HA 
coatings) is fragile when touching the coated metal during 
implantation and, like any HA coating, might delaminate or 
release particles over time (Bloebaum et al. 1994, Morscher et 
Background and purpose — Biological fi xation of 
uncemented knee prostheses can be improved by apply-
ing hydroxyapatite coating around the porous surface via a 
solution deposition technique called Peri-Apatite (PA). The 
2-year results of a randomized controlled trial, evaluating the 
effect of PA, revealed several components with continuous 
migration in the second postoperative year, particularly in 
the uncoated group. To evaluate whether absence of early 
stabilization is diagnostic of loosening, we now present 
long-term follow-up results.
Patients and methods — 60 patients were randomized 
to PA-coated or uncoated (porous only) total knee arthro-
plasty of which 58 were evaluated with radiostereometric 
analysis (RSA) performed at baseline, at 3 months postoper-
atively and at 1, 2, 5, 7, and 10 years. A linear mixed-effects 
model was used to analyze the repeated measurements.
Results — PA-coated components had a statistically 
signifi cantly lower mean migration at 10 years of 0.94 mm 
(95% CI 0.72–1.2) compared with the uncoated group show-
ing a mean migration of 1.72 mm (95% CI 1.4–2.1). Con-
tinuous migration in the second postoperative year was seen 
in 7 uncoated components and in 1 PA-coated component. 
All of these implants stabilized after 2 years except for 2 
uncoated components.
Interpretation — Peri-apatite enhances stabilization of 
uncemented components. The number of components that 
stabilized after 2 years emphasizes the importance of longer 
follow-up to determine full stabilization and risk of loosen-
ing in uncemented components with biphasic migration pro-
fi les.
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al. 1998). Only a few randomized RSA studies have assessed 
the short-term (2-year follow-up) effect of PA on uncemented 
tibial component migration (van der Linde et al. 2006, Hans-
son et al. 2008, Therbo et al. 2008, Molt and Toksvig-Larsen 
2014). All trials concluded that the PA coating appears to 
improve stabilization up to 2 years after implantation. How-
ever, no studies have examined long-term migration profi les 
of PA-coated tibial components. It is therefore unknown 
whether the found short-term effect on component fi xation is 
sustained over time. Furthermore, in the short-term report of 
the current study (Molt and Toksvig-Larsen 2014), a number 
of both uncoated and PA-coated components showed continu-
ous migration in the second postoperative year. It is unclear 
whether this leads to future aseptic loosening or if this high 
initial migration is merely part of a migration pattern typical 
for uncemented components. We therefore now report 10-year 
follow-up results of this double-blinded, randomized con-
trolled trial comparing implant migration measured with RSA 
and clinical results of PA-coated with uncoated uncemented 
TKAs.  
Patients and methods
Study design
Full details of the design and patient selection of this random-
ized controlled trial have been described previously (Molt and 
Toksvig-Larsen 2014). In short, all consecutive patients sched-
uled to undergo TKA due to primary osteoarthritis from July 
2007 until February 2008 in Hässleholm Hospital (Sweden) 
were asked to participate. 60 patients were randomized in a 
1:1 ratio. Patients received either “PA-coated” (applied on 
both the femoral and tibial component) or “uncoated” com-
ponents of an otherwise identical (fully) uncemented cruciate 
retaining Triathlon total knee prosthesis (Stryker, Mahwah, 
NJ, USA). The porous undersurface (in both versions) con-
sisted of cobalt-chromium sintered beads with a porosity of 
35% and mean pore size of 425 µm. Highly cross-linked poly-
ethylene inserts were used in all cases. 
At all follow-up points, the Knee Society Score (KSS) and 
the Knee injury and Osteoarthritis Outcome Score (KOOS) 
were obtained. Both patients and observers performing clini-
cal follow-up and RSA measurements remained blinded to the 
allocated group during the entire follow-up period. 
Radiostereometric analysis
RSA radiographs were made on the fi rst day after surgery 
when weight bearing was achieved. Subsequent examina-
tions were performed after 3 months, 1 year, 2, 5, 7, and 10 
years. RSA radiographs were performed in supine position 
with the knee in a calibration cage (Cage 10, RSA Biomedi-
cal, Umeå, Sweden). RSA measurements were analyzed using 
UmRSA software (v6.0, RSA, Biomedical, Umeå, Sweden). 
Positive directions along and about the orthogonal axes are 
according to RSA guidelines (Valstar et al. 2005). Migration 
was described as translation of the geometric center of the 
prosthesis markers and rotation of the rigid body defi ned by 
the prosthesis markers about this geometric center of gravity. 
The length of the translation vector of the marker or virtual 
marker in a rigid body that has the greatest migration, i.e., 
the maximum total point motion (MTPM), was used as the 
primary outcome measure (ISO 16087:2013(E) 2013). The 
fi rst postoperative RSA examination served as the reference 
for the migration measurements. Individual components with 
“continuous migration,” defi ned by Ryd et al. (1995) as an 
increase in MTPM of 0.2 mm or more in the second post-
operative year, were classifi ed as “loose.” This threshold was 
set at 0.1 mm per year after 2-year follow-up according to 
the modifi ed continuous migration criterion (Ryd et al. 1995). 
Consequently, implants classifi ed in the second postoperative 
year as loose were considered stabilized if the migration was 
less than 0.1 mm/year between 2-year and fi nal follow-up 
(Wilson et al. 2012, Molt et al. 2016). The precision of the 
local RSA set-up after the 2-year follow-up period, specifi ed 
as the 95% confi dence interval (CI) around zero motion, and 
measured with 15 double examinations (ISO 16087:2013(E) 
2013), was 0.10 mm, 0.10 mm, and 0.09 mm for transverse, 
longitudinal, and sagittal translations; 0.20°, 0.20°, and 0.24° 
for transverse, longitudinal, and sagittal rotations, respec-
tively. The mean error of rigid body fi tting of the RSA mark-
ers was below 0.35 mm and the upper limit for the condition 
number was set at 120, complying with the suggested limits 
of the RSA guidelines (ISO 16087:2013(E) 2013). The mean 
condition number was 40 (CI 37–42) and 51 (CI 49–54) for 
the implant and tibial markers, respectively.
Statistics
Given the high accuracy of RSA measurements, only 17 
patients were needed in each group to detect a decrease in 
migration from 1.0 to 0.5 ± 0.5 mm with 80% power and 
alpha set at 0.05, as described previously (Molt and Toksvig-
Larsen 2014). 30 patients were randomized to each group to 
account for possible dropouts. The original primary outcome 
reported by Molt and Toksvig-Larsen (2014) was a differ-
ence in migration (MTPM) after 2 years of follow-up. For 
this long-term outcome report, the primary outcome was a 
difference in MTPM after 10 years of follow-up as registered 
at ClinicalTrials.gov (ID: NCT03198533). Data were ana-
lyzed according to the intention-to-treat principle. A linear 
mixed-effects model was used for all repeated measurements 
to effectively deal with missing values within patients during 
follow-up. As MTPM is always a positive vector, normal dis-
tribution was only obtained after log-transformation (logM-
TPM), computed as log10(MTPM+1). Differences in mean 
progression of logMTPM between groups were modeled as 
a function of time and the interaction of time with treatment. 
A random-intercepts term was used and remaining variability 
was modelled with a heterogeneous autoregressive order 1 
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covariance structure. Secondary outcomes (RSA translations 
and rotations, fl exion, extension, KSS, and KOOS scores) 
were analyzed with a similar mixed-effects model. Differ-
ences in mean migration along and about each orthogonal 
axis were calculated using log-transformed absolute values 
(as the resultant of positive and negative displacement vectors 
requires all vectors to act on the same prosthesis) (Derbyshire 
et al. 2009). Given the non-normal distribution of knee exten-
sion and the KSS knee score (not resulting in a normal distri-
bution after a log transformation), a comparable generalized 
estimating equations (GEE) approach was used to correct 
the standard errors via the sandwich estimator. Post hoc test-
ing was performed to estimate between-group differences in 
MTPM using 3 months, 1 year, and 2 years as the reference. 
IBM SPSS Statistics 24.0 (IBM Corp, Armonk, NY, USA) 
was used for all outcome measures; a p-value < 0.05 was con-
sidered signifi cant. 
Ethics, registration, funding, and potential confl icts 
of interest
The trial was performed in compliance with the Declaration 
of Helsinki and Good Clinical Practice guidelines. This trial 
was approved by the local ethics committee prior to enroll-
ment (entry no. 445/2005) and registered at ClinicalTrials.
gov (new ID: NCT03198533, originally registered in 2007 
as a sub-study of NCT00436982). Informed consent was 
obtained from all patients. Stryker provided funds in support 
of the costs associated with RSA radiographs and extra clini-
cal follow-up examinations. The sponsor did not take any part 
in the design, conduct, analysis, and interpretations stated in 
the fi nal manuscript.
Results
60 patients were randomized, of which 1 patient in each group 
was excluded on the day of surgery. Baseline characteris-
tics were similar (Table 1). During follow-up, 3 knees were 
revised (2 infections and 1 loosening, see adverse events), 7 
patients died, 14 patients refused further follow-up due to the 
burden of coming to the clinic at high age or moving out of 
the region, and 2 patients could not be analyzed reliably for 
technical reasons (Figure 1). Of the 2 cases with unreliable 
measurements, 1 had insuffi cient bone markers available caus-
ing high condition numbers (up to 216) after 1 year; reversed 
RSA migration results showed stable minor translations, and 
this patient had no knee complaints and no signs of loosening 
on conventional radiographs. The other case had unreliable 
measurements after 5 years (condition number of 135) due to 
over-projection of the femoral component and this component 
was revised after 10 years for mechanical failure (see below). 
RSA migration measurements
PA-coated components stabilized earlier as compared with 
uncoated components, resulting in a lower mean migration 
at 10 years: 0.94 mm (CI 0.72–1.2) for the PA-coated group 
and 1.7 mm (CI 1.4–2.1) for the uncoated group (p < 0.001). 
Over time, differences in migration between groups were seen 
in almost any direction (Table 2). Most of the difference in 
migration was already seen at 1 year, as the PA-coated com-
ponents stabilized within the fi rst 3 months while the uncoated 
components stabilized after 1 year of follow-up (Figure 2). 
Post hoc analysis showed that when using different baselines, 
Table 1. Baseline demographic characteristics. Values 
are mean (SD) unless otherwise specifi ed
  Uncoated PA-coated
  (n = 29) (n = 29)
Age 67 (6.8) 65 (8.1)
Body mass index  30 (4.3) 30 (4.9)
Female sex (n)  16 17
Previous knee surgery (n)
 none  22 25
 joint debridement   1   1
 meniscectomy   5   2
 other   1   1
Ahlbäck’s grade (n)
 II 12   6
 III 15 22
 IV   2   1
ASA classifi cation (n)
 I   8   6
 II 20 21
 III   1   2
Hip–knee–ankle angle
 preoperative 175 (5.0) 176 (6.2)
 postoperative 179 (2.8) 179 (3.2)
Randomized (n = 60)
Allocated to PA-coated TKA (n = 30):
– received allocated treatment, 29
– excluded day of surgery due to
   cerebral infarct, 1
Allocated to uncoated TKA (n = 30):
– received allocated treatment, 29
– received cemented TKA due to
   an intraoperative fracture, 1
Lost to follow-up (n = 13):
– died after 1 and (2x) 5 years, 3
– withdrew after (3x) 1, (3x) 2, 
   (2x) 5 and 7 years, 9
– technical error after 2 years, 1 b
Lost to follow-up (n = 12):
– revised, 3 a
– died after 1, (2x) 2 and 7 years, 4
– withdrew after 1, 5 and 
   (3x) 7 years, 5
RSA analyzed:
Postop: 29
3 months: 28
1 year: 25
2 years: 25
5 years: 16
7 years: 20
10 years: 17
RSA analyzed:
Postop: 29
3 months: 29
1 year: 28
2 years: 25
5 years: 16
7 years: 17
10 years: 16
Enrollment
Analysis
Follow-up
Allocation
Figure 1. CONSORT fl ow diagram. TKA = total knee arthroplasty. a revised 
after 3 months (early infection), 1 year (late infection), and 10 years (mechan-
ical failure). b clinical follow-up only, see text.
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no statistically signifi cant between-group mean differences 
were seen from 1 year onwards (p = 0.1) and from 2 years 
onwards (p = 0.7) (Table 3, see Supplementary data).
Between 1 and 2 years of follow-up, 7 uncoated components 
showed more than 0.2 mm MTPM and were suspected for 
loosening, compared with 1 in the PA-coated group. 5 of the 7 
uncoated components stabilized, while 2 did not: 1 (clinically 
still asymptomatic patient) showed continuous migration of 
0.14 mm/year up to 10-year follow-up (Figure 3, see Supple-
mentary data) and 1 showed continuous migration of 0.11 
mm/year up to 7-year follow-up who, despite having progres-
sive complaints, refused to visit for 10-year follow-up (Figure 
4, see Supplementary data). 1 uncoated component that was 
initially classifi ed as loose was lost to follow-up but showed 
full stabilization at fi nal (5-year) follow-up. 1 uncoated com-
ponent was revised after 10 years as the patient had increasing 
pain and instability due to mechanical failure (see below). The 
PA-coated component initially classifi ed as loose was stabi-
lized at 5-year follow-up. None of the PA-coated components 
classifi ed as stable showed continuous migration at any fol-
low-up measurement beyond 2 years. 
Clinical results and adverse events
There were no statistically signifi cant between-group differ-
ences with respect to improvement in knee fl exion, extension, 
both KSS scores, and 4 of 5 KOOS subscales. The KOOS 
subscale quality of life improved equally between groups up 
to 5-year follow-up (p = 1.0), but substantially decreased in 
the PA-coated group between 5 and 10 years, resulting in a 
between-group mean difference after 10-year follow-up (p = 
0.02) (Table 4, see Supplementary data). 
3 patients (all with uncoated components) underwent revi-
sion surgery; the fi rst due to an early prosthetic joint infection 
(at 3 months), the second due to a late infection (at 1 year) and 
the third (at 10 years) due to mechanical failure (complaints 
of pain and instability, posteromedial wear of the insert, and 
tibial component loosening was found during revision surgery) 
(Figure 5, see Supplementary data). 1 patient (randomized to 
Table 2. RSA migration measurements in absolute mm or degrees (95% CI) (log-transformed values are back-transformed in the original 
scale)
 1 year 2 years 10 years 
 Uncoated  PA-coated Uncoated PA-coated Uncoated PA-coated p-value a
Translations (mm):
 Transverse 0.4 (0.28–0.49) 0.3 (0.21–0.40) 0.4 (0.33–0.54) 0.3 (0.19–0.38) 0.4 (0.30–0.54) 0.4 (0.24–0.48) 0.2
 Longitudinal 0.5 (0.42–0.67)  0.3 (0.18–0.39) 0.5 (0.41–0.66) 0.3 (0.17–0.38) 0.5 (0.41–0.69) 0.3 (0.17–0.41) < 0.001
 Sagittal 0.5 (0.42–0.68) 0.3 (0.17–0.38) 0.7 (0.52–0.80) 0.2 (0.13–0.34) 0.7 (0.55–0.87) 0.3 (0.17–0.42) < 0.001
Rotations (º):
 Transverse 1.1 (0.79–1.37) 0.6 (0.39–0.83) 1.2 (0.92–1.55) 0.6 (0.35–0.80) 1.3 (0.94–1.64) 0.6 (0.33–0.83) < 0.001
 Longitudinal 0.7 (0.50–0.82) 0.3 (0.17–0.42) 0.8 (0.67–1.04) 0.3 (0.18–0.44) 1.0 (0.78–1.21) 0.3 (0.14–0.43) < 0.001
 Sagittal 0.6 (0.49–0.83) 0.4 (0.30–0.59) 0.8 (0.66–1.04) 0.5 (0.36–0.67) 0.8 (0.57–0.97) 0.5 (0.30–0.65) 0.004
MTPM (mm) 1.5 (1.24–1.88) 0.9 (0.71–1.18) 1.7 (1.35–2.01)  0.9 (0.70–1.17) 1.7 (1.41–2.08) 0.9 (0.72–1.19) < 0.001
a p-values stated in this column indicate testing the between-group mean differences with time over the entire postoperative follow-up period. 
2.5
2.0
1.5
1.0
0.5
0
MTPM (mm)
MTPM (mm)
0 1 2 3 4 5 6 7 8 9 10
Years after index operation
0 1 2 3 4 5 6 7 8 9 10
Years after index operation
0
1
2
3
4
5
6
7
8
9
Uncoated
PA-coated
Loose (uncoated)
Stabilized (uncoated)
Stabililzed (PA-coated)
Revised (uncoated)
Figure 2. Maximum total point motion (back-transformed in the original 
scale in mm) during 10 years of follow-up: (top) the mean and 95% 
CI for the groups and (bottom) the mean and 95% CI for the groups 
and separate lines for the components showing continuous migration 
in the second postoperative year (in green the stabilized components 
after 2 years, in dashed brown the components failing to stabilize after 
2 years and suspected for aseptic loosening, and in solid brown the 
revised component).
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the uncoated group) received a cemented implant due to an 
intraoperative fi ssure of the proximal tibia and was excluded. 
1 patient (randomized to the PA-coated group) was transferred 
on the day of surgery to another hospital to receive appropriate 
treatment after a cerebral infarct and was also excluded.  
Discussion
Our results show that the short-term effect of Peri-Apatite™ 
on uncemented tibial component migration is sustained over 
time, resulting in less mean migration and absence of com-
ponents with continuous migration after 10 years. As shown 
in other long-term RSA studies, stabilization of uncemented 
tibial components can be achieved despite high initial migra-
tion (Pijls et al. 2012a, Henricson and Nilsson 2016). In the 
present long-term study, 6 individual components stabilized 
even after 2 years. Only 2 uncoated components migrated 
continuously throughout follow-up. Given that most prosthe-
ses stabilized within 2 years, the mean migration from 1 year 
onwards was not statistically signifi cantly different between 
groups as confi rmed in the post hoc analysis.
Both “excessive” initial migration in the fi rst year (of more 
than 0.5 mm for a group of patients) and continuous migration 
after 1 year (0.2 mm in the second postoperative year for an 
individual patient) are associated with, and frequently used as 
predictors for, aseptic loosening (Ryd et al. 1995, Pijls et al. 
2012b). These studies, however, combined prostheses that rely 
on primary fi xation (cemented and uncemented with screws) 
and those that rely on secondary biological fi xation (unce-
mented) to evaluate the migration thresholds for prostheses 
suspected for loosening. Several studies have shown that the 
typical migration pattern of an uncemented component differs 
from that of a primary fi xated component, especially during 
the fi rst 2 years (Nilsson et al. 2006, Dunbar et al. 2009, Pijls 
et al. 2012a, Wilson et al. 2012, Henricson and Nilsson 2016, 
van Hamersveld et al. 2017). We therefore question whether 
the current migration thresholds are justifi ed for uncemented 
prostheses, especially for designs without biological media-
tors (e.g., hydroxyapatite or highly porous metal) to enhance 
bone ingrowth, and can be used to classify such implants 
being loose in RSA studies with only 2 years of follow-up. 
In our study, 1 TKA was revised at 10-year follow-up due 
to progressive pain and function impairment due to mechani-
cal failure. Posteromedial polyethylene wear and tibial com-
ponent loosening was found during revision surgery (Figure 
5, see Supplementary data). This patient was not fl agged as 
“loose” through RSA measurements as MTPM values were 
stable up to 5 years of follow-up but further follow-up mea-
surements were unreliable due to high condition numbers 
(solid red line in Figure 2). The exact failure mechanism is 
unknown. Causal factors of posteromedial failure include 
overloading the medial compartment and malalignment of the 
femoral component, increasing posteromedial peak contact 
stresses (Morra et al. 2003). Some authors have reported that 
by cross-linking the polyethylene the fatigue crack propaga-
tion resistance is decreased, especially in TKA (Bradford et 
al. 2004, Ries 2005). However, later reports of fatigue failure 
are rare and mainly limited to tibial post fractures in poste-
rior-stabilized knees, suggesting this mechanism is unlikely 
to account for failure in our patient (Jung et al. 2008, Yu et al. 
2016). 
Although all other subscales of the KOOS score were similar 
between uncoated and PA-coated components, we did observe 
a statistically signifi cant difference in the quality of life sub-
scale after 10 years of follow-up. Similar to the occurrence of 
both the infection cases and the revised case due to mechani-
cal failure (which could all have occurred in either group), the 
statistical difference in quality of life is most likely a spuri-
ous fi nding and not related to the implant type. Nevertheless, 
we continue to monitor these patients to observe whether any 
adverse effect of the given treatment occurs. 
Several limitations can be noted. First, a high number of 
patients were lost to follow-up. Consequently, only 16 patients 
were available for analysis in the PA-coated group at 10-year 
follow-up. However, results from the linear mixed-effects 
model are based on all measurements, not only on remain-
ing patients at fi nal follow-up. Furthermore, as most implants 
of the lost patients appeared to have stabilized, it is unlikely 
that the observed results would substantially differ from those 
presented if patients had continued follow-up. Results of the 
secondary clinical outcomes should, however, be regarded as 
exploratory due to the limited sample size and the lower accu-
racy and precision of these outcome measurements. Second, 
it remains unknown why 6 components stabilized while 2 did 
not. Logically, the magnitude of component migration plays 
a role in preventing the onset of a prosthesis-settling phase. 
However, other (baseline) factors that may predict high risk 
patients cannot be found without performing “one-variable-
at-a-time” subgroup analyses, which are likely both under-
powered and produce false-positive results due to multiple 
comparisons (Kent et al. 2016). We therefore refrained from 
performing such subgroup analyses. Third, a strict intention-
to-treat analysis requires all randomized patients to be ana-
lyzed, which was not the case for the 2 excluded patients on 
the day of surgery. These 2 patients were excluded from fur-
ther follow-up measurements at the time, hence no data were 
available for analysis. Furthermore, not receiving the studied 
intervention can be a legitimate reason for patient exclusion 
without risking bias, even in an intention-to-treat trial (Fergus-
son et al. 2002). 
In summary, the typical biphasic migration pattern of unce-
mented implants was seen in both the uncoated group and the 
PA-coated group, but the latter showed statistically signifi -
cantly less mean migration and absence of components with 
continuous migration at 10-year follow-up. When evaluating 
uncemented prostheses, especially those without biological 
mediators to enhance bone ingrowth, the initial migration 
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phase is longer than in cemented components and can last 
over 2 years. With such prostheses, short-term RSA cut-off 
values to determine the risk of failure seem of limited value. 
Evaluation should thus be based on longer follow-up data and 
include mean migration results as well as individual compo-
nent migration results. 
Supplementary data
Tables 3 and 4 and Figures 3–5 are available in the online 
version of this article, http://dx.doi.org/ 10.1080/17453674. 
2018.1469223
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